Income Statement
BIOXCEL THERAPEUTICS, INC.
BTAI
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY |
|---|---|---|---|---|---|---|---|---|
|
Revenue
|
0.64 | 2.27 | 1.38 | 0.38 | - | - | - | - |
|
Cost of Revenue
|
0.16 | 2.14 | 1.26 | 0.02 | - | - | - | - |
|
Gross Profit
|
0.48 | 0.12 | 0.12 | 0.36 | - | - | - | - |
|
Operating Expenses
|
50.75 | 64.93 | 167.74 | 160.00 | 106.94 | 82.30 | 33.60 | 19.96 |
|
Research & Development
|
30.25 | 30.44 | 84.33 | 91.24 | 52.71 | 58.00 | 25.80 | 14.56 |
|
Selling, General & Administrative
|
20.49 | 34.49 | 83.41 | 68.76 | 54.23 | 24.30 | 7.80 | 5.40 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - |
|
Operating Income
|
-50.27 | -64.80 | -167.62 | -159.65 | -106.94 | -82.30 | -33.60 | -19.96 |
|
Non-Operating Income
|
- | - | - | - | - | - | - | - |
|
Interest Income
|
1.07 | 2.60 | 5.65 | 2.53 | 0.04 | - | - | - |
|
Interest Expense
|
15.33 | 14.66 | 13.31 | 8.21 | 0.04 | 0.03 | - | - |
|
Other Non-Op Income / Expense
|
-3.52 | 20.17 | 0.39 | -0.43 | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - |
|
Net Income
|
-69.90 | -59.60 | -179.05 | -165.76 | -106.93 | -82.17 | -32.97 | -19.27 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY |
|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - |
|
EBITDA
|
-50.27 | -64.80 | -167.62 | -159.65 | -106.64 | -82.11 | -33.45 | -19.95 |
|
Earnings Per Share (Basic)
|
-5.73 | -23.51 | -6.15 | -5.92 | -4.05 | - | - | - |
|
Diluted EPS
|
-5.73 | -23.51 | -6.15 | -5.92 | -4.05 | - | - | - |
|
Weighted Average Shares
|
12.21 | 2.54 | 29.13 | 28.02 | 26.37 | - | - | - |
|
Diluted Weighted Avg Shares
|
12.21 | 2.54 | 29.13 | 28.02 | 26.37 | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - |